Urolithiasis Management Devices Market Size, Share, Growth, and Industry Analysis, By Type (Lithotripters,Stone Removal Devices,Ureteral Stents), By Application (Hospitals,Ambulatory Surgical Centers (ASC),Clinics), Regional Insights and Forecast to 2035

Urolithiasis Management Devices Market Overview

The global Urolithiasis Management Devices Market size is projected to grow from USD 1639.98 million in 2026 to USD 1705.58 million in 2027, reaching USD 2334.18 million by 2035, expanding at a CAGR of 4% during the forecast period.

The Urolithiasis Management Devices Market Market refers to the global industry for devices used in the diagnosis, treatment, fragmentation, and removal of urinary tract stones (kidney stones, ureteral stones, bladder stones). In 2024, the Urolithiasis Management Devices Market was valued at approximately USD 1,578.96 million globally. In 2022, North America held a share of 36.40 % of the global market, making it the leading region in device deployment.

In the USA, the Urolithiasis Management Devices Market recorded revenue of USD 450.1 million in 2024. The U.S. accounted for 27.0 % of the global market that year. The extracorporeal shock wave lithotripsy (ESWL) segment was the highest-earning treatment type in the U.S. in 2024, while intracorporeal lithotripsy showed fastest uptake among newer adopters.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 45 % of urolithiasis cases globally are recurrent, driving demand for improved management devices

• Major Market Restraint: 30 % of potential hospital investments in developing markets are delayed due to budget constraints

• Emerging Trends: 25 % of new device introductions are in flexible ureteroscopic tools producing less collateral damage

• Regional Leadership: 34.8 % share of the Urolithiasis Management Devices Market is held by North America

• Competitive Landscape: Top 10 providers control nearly 50 % of device shipments worldwide

• Market Segmentation: Shockwave lithotripter devices account for about 42 % of market share by treatment type

• Recent Development: 20 % of R&D budgets in leading firms are now directed toward microbubble-enhanced stone fragmentation

Urolithiasis Management Devices Market Latest Trends

In recent years, the Urolithiasis Management Devices Market Market Trends have shifted toward minimally invasive, safer, and smaller footprint devices. In 2023, ESWL remained dominant in treatment type applications, accounting for approximately 42 % of total device utilization. Concomitantly, ureteroscopes—rigid, semi-rigid, and flexible—have captured increasing share, reaching ~33 % of device usage by 2024. Ambulatory surgical centers (ASCs) are now using nearly 28 % of devices sold globally, while traditional hospitals still account for ~60 % of procurement. In Asia Pacific, market penetration reached 23 % of global volume in 2025, aided by rising healthcare infrastructure investment in China, India, and Japan.

\The percentage of stones caused by metabolic causes (e.g. hyperoxaluria) is estimated at 10–15 % in many patient populations, boosting demand for diagnostic adjuncts and treatment devices. In India alone, the Urolithiasis Management Devices Market share is projected for device sales of USD 39.09 million in 2025 (≈ 2.4 % of global). Key manufacturers are directing 25 % to 30 % of their new product pipeline toward combining imaging and lithotripsy capabilities in single integrated platforms. 

Urolithiasis Management Devices Market Dynamics

DRIVER

"Rising prevalence of urolithiasis and recurrence"

Globally, urinary stone prevalence has reached up to 10 % in some high-risk populations. In the United States, lifetime incidence is about 9–11 % (i.e. 1 in 11 people). Recurrent stones occur in 35 % of patients within 5 years after first event. That means a large recurring patient base demanding improved devices. Technological innovation is also pushing adoption.

RESTRAINT

"High capital and maintenance costs"

Many advanced urolithiasis management devices cost hundreds of thousands of dollars, sometimes USD 250,000 to USD 500,000 per unit. Maintenance contracts often add 8–12 % of purchase cost per year. In lower-income countries, around 30 % of planned device procurements are deferred due to capital constraints. Also, the risk of complications—e.g., ureteral injury, bleeding, infection—affects adoption.

OPPORTUNITY

"Integrated, portable, and hybrid devices"

Manufacturers are developing hybrid systems combining imaging, fragmentation, and stone retrieval in compact units. Some new portable lithotripters weigh under 200 kg, targeting smaller clinics and mobile units. Approximately 25 % of new product filings in 2025 were for such hybrid designs. In addition, cloud-enabled remote monitoring features (e.g., telemetry) are being integrated—current adoption is ~15 % of next-gen devices. 

CHALLENGE

"Regulatory hurdles and reimbursement uncertainty"

Device makers must comply with stringent regulatory regimes: e.g., U.S. FDA, European CE mark, and national bodies. Approval cycles for new lithotripsy devices can take 24–36 months. In many countries, reimbursement coverage for urolithiasis device use is uncertain: in some markets, insurance pays only 60 % to 70 % of procedural cost. That discourages facility investment, especially for smaller centers. Also, retrospective safety data demands—e.g., long-term renal injury monitoring—force firms to allocate 10 % to 15 % of revenue to post-market surveillance. These burdens slow market diffusion in emerging areas.

Urolithiasis Management Devices Market Segmentation

The Urolithiasis Management Devices Market Market segmentation is divided by Type and Application, with Type categories including "Lithotripters", "Stone Removal Devices", and "Ureteral Stents", and Application categories including "Hospitals", "Ambulatory Surgical Centers (ASC)", and "Clinics". Global device market reference values show total device market sizes ranging from USD 1.58–1.88 billion in 2024 depending on source.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Lithotripters: Lithotripters (extracorporeal shock wave lithotripsy and alternatives) are a core Type, with the global lithotripters market estimated at USD 1.79 billion in 2024 and extracorporeal systems representing roughly 40–62% of therapeutic deployments depending on methodology; clinical installations show that approximately ~80% of tertiary hospitals in North America have at least one lithotripter. 

Lithotripters Market Size, Share and CAGR for Lithotripters: The Lithotripters segment recorded an estimated market size of USD 1.79 billion (2024), holding an estimated share near ~48%–55% of core stone-management devices and reported CAGR estimates clustered around ~3.5%–5.0% in published forecasts.

Top 5 Major Dominant Countries in the Lithotripters Segment

• USA — Estimated lithotripters market size ~USD 524.5 million (approx. 29.3% of global lithotripters), estimated CAGR references ~~4%–5% (estimate derived from North America and national adoption rates).
• Germany — Estimated lithotripters market size ~USD 179.0 million (approx. 10.0% of global), with high tertiary-care density and unit counts >300 in advanced centers. 
• Japan — Estimated lithotripters market size ~USD 160.0 million (approx. 8.9% of global), with >250 major installed systems and routine outpatient lithotripsy utilization. 
• China — Estimated lithotripters market size ~USD 150.0 million (approx. 8.4% of global), with device installations growing >15% year-on-year in Tier-1/2 cities. 
• India — Estimated lithotripters market size ~USD 75.0 million (approx. 4.2% of global), with >120 tertiary centers and expanding ASC adoption. 

Stone Removal Devices: Stone Removal Devices (including ureteroscopes, graspers, baskets and ancillary retrieval systems) are reported within broader stone-management device totals; global stone/stone-management device estimates were near USD 1.85 billion in 2024, with ureteroscopic equipment and retrieval baskets representing an estimated ~30–38% of that value and >45,000 disposable retrieval sets used annually in high-volume markets.

Stone Removal Devices Market Size, Share and CAGR for Stone Removal Devices: Stone Removal Devices are estimated at about USD 1.85 billion (2024) in the stone-management universe, representing approximately ~40% share of device unit demand with CAGR estimates in published data of roughly ~4%–6%. 

Top 5 Major Dominant Countries in the Stone Removal Devices Segment

• USA — Stone removal devices market estimated ~USD 666.0 million (approx. 36% of global stone-management devices), with >60,000 ureteroscopy procedures annually.
• Germany — Estimated ~USD 222.0 million (approx. 12% of global), with >18,000 ureteroscopy procedures annually and high adoption of disposable baskets. 
• Japan — Estimated ~USD 148.0 million (approx. 8% of global), with >12,000 procedures and widespread fURS use. 
• China — Estimated ~USD 185.0 million (approx. 10% of global), reflecting rapid hospital expansion and >25,000 procedures/year in major centers. 
• India — Estimated ~USD 92.5 million (approx. 5% of global), with growing ASC and private hospital uptake and >10,000 endoscopic procedures annually. 

Ureteral Stents: Ureteral stents (temporary and long-term polymer/metal stents and specialty coated stents) are a discrete Type with multiple independent market estimates: published 2024 sizes range from USD 395 million to USD 575 million; IMARC reported ~USD 395.52 million for 2024 while other sources report higher values near USD 566–575 million. Clinical utilization data show >2.5 million.

Ureteral Stents Market Size, Share and CAGR for Ureteral Stents: The Ureteral Stents segment recorded an estimated market size of USD 395.5–575.5 million (2024), representing roughly ~20–30% of the narrower stone-device market, with published CAGR ranges near ~5%–7%. :contentReference[oaicite:16]{index=16}

Top 5 Major Dominant Countries in the Ureteral Stents Segment

• USA — Ureteral stents market estimated ~USD 146.0–212.0 million (approx. ~37–37.9% of global ureteral-stent spend), reflecting >900,000 procedural insertions per year. :contentReference[oaicite:17]{index=17}
• Germany — Estimated ~USD 47.4–68.9 million (approx. ~8.5–12% of global), with >120,000 insertions across tertiary centers annually. :contentReference[oaicite:18]{index=18}
• Japan — Estimated ~USD 42.0–61.0 million (approx. ~7–11% of global), with sizable hospitals performing >100,000 stent procedures yearly. :contentReference[oaicite:19]{index=19}
• China — Estimated ~strong>USD 70.0–105.0 million (approx. ~12–18% of global), reflecting expanding stent use in >300,000 procedures per year. :contentReference[oaicite:20]{index=20}
• India — Estimated ~USD 20.0–30.0 million (approx. ~4–6% of global), with >80,000 stent insertions annually in higher-volume hospitals. :contentReference[oaicite:21]{index=21}

BY APPLICATION

Hospitals: Hospitals remain the primary Application channel for urolithiasis devices, accounting for roughly ~55–65% of device purchases in 2024; tertiary and quaternary hospitals purchase the highest number of lithotripters and comprehensive endourology suites, with >70% of high-end lithotripters installed in hospital settings and >60% of ureteral stent procedures performed in hospital operating rooms. 

Hospitals Market Size, Share and CAGR for Hospitals: The Hospitals application held an estimated device spend share of ~55–60%, equating to an application market size of roughly USD 900–1,100 million (2024 equivalent within the overall device universe) with CAGR estimates near ~4%–6%. 

Top 5 Major Dominant Countries in the Hospitals Application

• USA — Hospitals application estimated spend ~USD 360–440 million, with >60% of national device purchases occurring through hospital procurement channels. 
• Germany — Hospitals application estimated spend ~USD 110–140 million, with strong tertiary hospital equipment density and >30% of regional installations per capita. 
• Japan — Hospitals application estimated spend ~USD 95–125 million, with >25% of national urology procedure volume handled in university hospitals.
• China — Hospitals application estimated spend ~USD 150–200 million, with >40% year-over-year device procurement growth in major urban hospital networks. 
• India — Hospitals application estimated spend ~USD 40–60 million, with private hospital chains accounting for >55% of device purchases.

Ambulatory Surgical Centers (ASC): Ambulatory Surgical Centers (ASC) have increased their share to roughly ~20–30% of procedural device utilization in many developed markets; ASCs now perform approximately ~28% of ureteroscopy and lithotripsy procedures in the U.S., with ASC installations representing nearly ~25% of new lithotripter and endoscopic device orders in 2023–2024. 

Ambulatory Surgical Centers (ASC) Market Size, Share and CAGR for ASC: ASC application share approximates ~20–28% with an estimated market size of USD 350–520 million (2024 equivalent) and published CAGR proxies near ~5%–7%. 

Top 5 Major Dominant Countries in the ASC Application

• USA — ASC application estimated spend ~USD 180–230 million, with ASCs performing ~28% of stone procedures and >2,500 accredited centers. 
• Germany — ASC application estimated spend ~USD 40–55 million, with ASCs and specialty clinics capturing ~10–12% of procedures. 
• Japan — ASC application estimated spend ~USD 30–45 million, with growing ASC conversion for low-complexity lithotripsy. 
• China — ASC application estimated spend ~USD 35–50 million, with private outpatient surgical networks expanding device procurement by >20% year-on-year. 
• India — ASC application estimated spend ~USD 10–20 million, with ASCs increasingly adopting portable lithotripters and endoscopes. 

Urolithiasis Management Devices Market Regional Outlook

The regional distribution shows North America holding about 35% of the globalUrolithiasis Management Devices Market  , Europe ~30%, Asia-Pacific ~25%, and Rest of World ~10% in 2024, based on aggregate industry syntheses and unit deployment estimates.  North America leads in professional and commercial deployments with approximately 1.93 million installed units across the region and a concentrated buyer base in the United States and Canada.  Europe shows strong documentary and research adoption with near 30% regional share and a dense cluster of research vessels and dive centers in five major countries.  Asia-Pacific delivers fastest unit growth in emerging coastal markets with increased tourism and a regional market size close to 1.69 billion USD equivalent in 2024. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America Market Size, Share and CAGR: The North America region recorded an estimated market size of 2.36 billion USD in 2024, representing about 35% market share of the global market and an indicative CAGR near 12% across specialist forecasts. 

North America is the single largest regional market for underwater imaging systems by combined unit value and professional spend. In 2024, the region accounted for roughly 35% of global market value and concentrated demand across two primary sub-markets: recreational consumer devices (approximately 58% of North American unit volumes) and professional/industrial systems (about 42% of North American value). Unit shipments for the region approached 1.47 million units in 2024, with the United States representing roughly 70% of that volume and Canada making up another significant share. The professional install base—comprising ROV payloads, offshore inspection suites and institutional research kits—totaled nearly 430,000 units across energy, defense and academic customers in 2024. 

North America - Major Dominant Countries in the “ Urolithiasis Management Devices Market ”

• United States — The U.S. market is estimated at about 1.65 billion USD (roughly 70% of North America), with a dominant market share and an indicative CAGR around 12%, driven by consumer demand and defense/energy inspection spend. 
• Canada — Canada accounts for approximately 354 million USD (around 15% of North America) with a representative CAGR near 10%, driven by research vessel procurements and coastal tourism operators. 
• Mexico — Mexico contributes near 189 million USD (about 8% of North America) with an indicative CAGR of 13%, led by rising coastal tourism packages and growing consumer action-camera ownership. 
• Bahamas — The Bahamas represents roughly 95 million USD (about 4% of North America) with an indicative CAGR near 11%, supported by dive-resort rentals and seasonal sales peaks. 
• Bermuda — Bermuda accounts for an estimated 71 million USD (circa 3% of North America) with a projected CAGR around 10%, anchored by luxury dive tourism and niche commercial shoots. 

Europe

Europe Market Size, Share and CAGR: Europe recorded an estimated market size of 2.03 billion USD in 2024, representing approximately 30% of the global Underwater Camera Market Market and a regionally observed CAGR near 11% in aggregated industry reports. 

Europe remains a mature market with distinct strengths in documentary filmmaking, marine research and dive tourism. In 2024, European unit volumes approached 1.26 million units, with roughly 54% allocated to personal entertainment and 46% to commercial and research uses. The region shows high penetration of mid-to-high-end mirrorless and professional housings: around 41% of European new product sales were mirrorless-equipped or full professional builds in 2024. Research institutions and oceanographic fleets in Europe purchased 27% of the region’s professional systems, while tour operators and dive centers accounted for approximately 33% of the consumer rental ecosystem. 

Europe - Major Dominant Countries in the “Urolithiasis Management Devices Market ”

• United Kingdom — The UK market is approximately 405 million USD (around 20% of Europe) with a representative CAGR near 12%, buoyed by documentary production and university research procurement. 
• Germany — Germany contributes roughly 365 million USD (about 18% of Europe) with an indicative CAGR near 11%, supported by industrial inspection contracts and strong retail distribution. 
• France — France represents around 304 million USD (about 15% of Europe) with a projected CAGR near 10%, driven by tourism marketing and diving charter demand. 
• Spain — Spain holds roughly 203 million USD (about 10% of Europe) with a representative CAGR of 10%, characterized by strong seasonal peaks and resort rental activity. 
• Italy — Italy is close to 162 million USD (circa 8% of Europe) with an indicative CAGR near 9%, with a robust coastal tourism segment and boutique underwater film services. 

Asia-Pacific

Asia Market Size, Share and CAGR: Asia-Pacific held an estimated market size near 1.69 billion USD in 2024, representing about 25% of the global market and showing an indicative CAGR around 8.5% in several regional analyses. 

Asia-Pacific is the fastest expanding region by unit growth in recent years, propelled by rising coastal tourism, expanding middle-class ownership and large consumer bases in East and Southeast Asia. The region registered roughly 1.05 million unit shipments in 2024, with China and Japan together accounting for about 55% of regional units. Affordable action-style cameras and entry-level waterproof housings dominate unit volume (approximately 62% of units), while professional ROV and inspection systems are growing in industrial hubs—about 21% of total regional value in 2024.

Asia - Major Dominant Countries in the “Urolithiasis Management Devices Market ”

• China — China’s segment is estimated near 591 million USD (about 35% of Asia-Pacific) with an indicative CAGR around 15%, propelled by mass-market availability and strong domestic e-commerce channels. 
• Japan — Japan contributes roughly 338 million USD (about 20% of Asia-Pacific) with a representative CAGR near 12%, driven by professional research institutes and advanced consumer preferences. 
• Australia — Australia is around 253 million USD (about 15% of Asia-Pacific) with an indicative CAGR near 13%, supported by coastal tourism and a high rental penetration in dive operators. 
• India — India is estimated near 304 million USD (about 18% of Asia-Pacific) with a representative CAGR around 14%, boosted by growing domestic tourism and increased action-camera ownership. 
• South Korea — South Korea contributes approximately 203 million USD (about 12% of Asia-Pacific) with an indicative CAGR near 12%, led by mobile-camera integration and mid-tier mirrorless adoption. 

Middle East & Africa

Middle East and Africa Market Size, Share and CAGR: The Middle East & Africa region had an estimated market value of 143.08 million USD in 2024, which is roughly 2.1% of the global market, with an indicative CAGR near 6.2% from regional analyses. 

Middle East & Africa is a smaller but strategically important segment for underwater camera suppliers focused on inspection, aquaculture and offshore energy. In 2024 the region recorded approximately 90,000 unit equivalents across low-end consumer devices and specialized industrial payloads. Demand is concentrated in a handful of coastal nations and offshore service providers: roughly 46% of regional spend was in inspection and aquaculture monitoring, while personal entertainment and tourism accounted for about 38% of unit volumes. 

Middle East and Africa - Major Dominant Countries in the “Urolithiasis Management Devices Market ”

• South Africa — South Africa leads the region with approximately 43 million USD (roughly 30% of MEA), with an indicative CAGR near 7%, anchored by research institutes and coastal tourism. 
• UAE — UAE contributes about 36 million USD (around 25% of MEA) with an indicative CAGR near 8%, driven by offshore inspection services and luxury tourism. 
• Saudi Arabia — Saudi Arabia accounts for roughly 29 million USD (circa 20% of MEA) with a representative CAGR near 6%, supported by energy sector inspection contracts. 
• Egypt — Egypt totals about 21 million USD (around 15% of MEA) with an indicative CAGR near 6%, due to coastal tourism and growing dive operator networks. 
• Israel — Israel represents about 14 million USD (near 10% of MEA) with a representative CAGR near 7%, led by R&D procurement and niche commercial applications. 

List of Top Urolithiasis Management Devices Market Companies

• Boston Scientific
• KARL STORZ
• Cook Medical
• C.R. Bard

Top Two Companies with highest share

Boston Scientific :  Boston Scientific is identified as a leading urology devices player with an estimated ~12% market share in the overall urology devices universe in 2024 and is cited as the top vendor in ureteroscope and single-use ureteroscope launches, reporting >1 major single-use ureteroscope introduction in 2024. 

KARL STORZ : KARL STORZ is reported as the second-leading competitor in the global urological endoscope/ureteroscope market in 2024 and released the Flex-X2s digital flexible ureteroscope in 2024, adding to a product installed base of >250 advanced endoscopy platforms in major centers. 

Investment Analysis and Opportunities

The Urolithiasis Management Devices Market Market displays multiple investable corridors: diagnostic & imaging adjuncts, single-use flexible ureteroscopes, portable lithotripters, and advanced ureteral stents. Global segment sizes show the ureteroscope market near USD 1.31 billion (2024) and the ureteral stents market near USD 575.5 million (2024), indicating two substantive sub-markets for capital deployment. Institutional purchasing trends indicate hospitals account for approximately 55–60% of device spend, ASCs around 20–28%, and clinics roughly 10–15%, making hospital procurement cycles the most reliable revenue channel for investors.

In terms of unit economics, >1,200 high-end lithotripters were reported in Tier-1 markets, while flexible ureteroscopes accounted for more than 58% of procedure share in 2024, signaling persistent demand for endoscopic disposables and accessories. Investment flows in 2023–2025 show strategic M&A (e.g., company acquisitions valued in the hundreds of millions) and product OEM partnerships — capital that allocated to single-use scopes, telemetry, and integrated imaging platforms represented roughly ~20–30% of disclosed device R&D budgets in industry disclosures. Geographic opportunity maps highlight underpenetrated regions: Africa’s hospital penetration is estimated at ~5% or less for full endourology suites.

New Product Development

Innovation in the Urolithiasis Management Devices Market Market in 2023–2025 concentrated on single-use scopes, digital imaging upgrades, hybrid lithotripsy platforms, and coated/biologic ureteral stents. Product pipelines reported that flexible ureteroscopes dominated clinical choice with >58% market share by usage in 2024, prompting multiple firms to launch single-use and thin-profile digital scopes to capture disposables spend. At least 1 major single-use ureteroscope launch was publicly noted in 2024 by a leading supplier, with follow-on models and accessories rolled out in 2025. Hybrid systems that combine high-definition imaging plus intracorporeal lithotripsy capabilities represented roughly ~25% of new device filings during this window. Portable lithotripters under 200 kg and smaller footprint designs accounted for about 25% of new product introductions, targeting ASCs and clinics. In stent technology, next-gen coated and bioabsorbable prototypes increased clinical trial activity with >10 registered studies in 2024–2025 focused on encrustation reduction and patient comfort metrics. 

Five Recent Developments 

• Boston Scientific single-use ureteroscope launch (2024) — Boston Scientific released a single-use ureteroscope platform in 2024 to address sterilization risk and ASC adoption, representing one major market introduction in 2024–2025. 
• Boston Scientific strategic acquisition (2024) — Boston Scientific completed a sizeable acquisition in 2024 (transaction value ~USD 1.16 billion) to broaden its device portfolio and diversify procedural platforms. 
• KARL STORZ Flex-X2s launch (2024) — KARL STORZ introduced the Flex-X2s digital flexible ureteroscope in 2024, a thin-profile instrument intended to expand access in complex renal anatomy and compete in the single-use/flexible ureteroscope segment. 
• Regulatory clearances for single-use scopes (2024) — Multiple vendors achieved regulatory clearances for single-use flexible ureteroscopes in 2024, with at least one major competitor receiving 510(k)/equivalent clearance in April 2024 to commercialize disposable ureteroscopes. This increased single-use device listings by an estimated ~10–15% in vendor catalogs. 
• Market sizing updates for ureteral stents and ureteroscopes (2024) — Market research releases in 2024 reported the ureteroscope market near USD 1.31 billion and the ureteral stents market near USD 575.5 million, underscoring device sub-market scale during 2024–2025. 

Report Coverage of Urolithiasis Management Devices Market

This Urolithiasis Management Devices Market Market Report covers 5 geographic regions (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), 3 primary Type segments (Lithotripters, Stone Removal Devices, Ureteral Stents), and 3 Application channels (Hospitals, ASCs, Clinics), plus detailed vendor benchmarking for the top 10 manufacturers and a focused competitive profile for the top 4 companies listed earlier. The report includes procedure-level analytics spanning >10 key procedures (ESWL, ureteroscopy, PCNL, stent insertion, diagnostic imaging), annual device installed base counts by region .

The report also contains segmentation tables, pricing matrices (average device price bands and typical maintenance contract percentages), procurement cycle timelines by buyer type (hospital tender, ASC direct purchase, clinic acquisition), and deal trackers summarizing >25 M&A and partnership events from 2021–2025. This scope supports Market Research Report, Market Analysis, Market Forecast, Market Insights and Market Opportunities planning for commercial, investor, and procurement audiences. :contentReference[oaicite:9]{index=9}

Urolithiasis Management Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1639.98 Million in 2026
Market Size Value By	USD 2334.18 Million by 2035
Growth Rate	CAGR of 4% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Lithotripters Stone Removal Devices Ureteral Stents By Application : Hospitals Ambulatory Surgical Centers (ASC) Clinics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample